US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.4100
  • +0.0100+0.71%
Close Feb 14 16:00 ET
  • 1.3700
  • -0.0400-2.84%
Post 20:01 ET
6.62MMarket Cap-0.83P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.86%5.74M
-7.32%1.59M
33.40%1.47M
-21.29%1.3M
-24.50%1.38M
0.83%6.3M
48.47%1.71M
-18.36%1.1M
-25.43%1.66M
12.22%1.83M
Selling and administrative expenses
-8.47%4.32M
-18.44%1.06M
34.14%1.13M
-26.74%980.55K
-7.14%1.16M
52.21%4.72M
751.01%1.3M
-18.20%838.93K
26.28%1.34M
-4.27%1.25M
-General and administrative expense
-8.47%4.32M
-18.44%1.06M
34.14%1.13M
-26.74%980.55K
-7.14%1.16M
52.21%4.72M
751.01%1.3M
-18.20%838.93K
26.28%1.34M
-4.27%1.25M
Research and development costs
-10.45%1.38M
29.71%486.49K
31.04%345.88K
1.70%322.96K
-61.29%227.48K
-49.88%1.54M
-70.79%375.07K
-18.86%263.95K
-72.64%317.57K
76.75%587.63K
Depreciation amortization depletion
7.49%40.09K
----
----
----
----
-45.34%37.3K
----
----
----
----
-Depreciation and amortization
7.49%40.09K
----
----
----
----
-45.34%37.3K
----
----
----
----
Operating profit
8.86%-5.74M
7.32%-1.59M
-33.40%-1.47M
21.29%-1.3M
24.50%-1.38M
-0.83%-6.3M
-48.47%-1.71M
18.36%-1.1M
25.43%-1.66M
-12.22%-1.83M
Net non-operating interest income expense
297.24%235.06K
210.34%55.51K
391.27%85.02K
469.14%33.96K
236.25%60.58K
510.45%59.17K
224.06%17.89K
255.54%17.31K
5.97K
18.02K
Non-operating interest income
287.09%271.22K
218.52%91.67K
391.27%85.02K
469.14%33.96K
236.25%60.58K
--70.07K
--28.78K
--17.31K
--5.97K
--18.02K
Non-operating interest expense
231.94%36.16K
----
----
----
----
-24.44%10.89K
----
----
----
----
Other net income (expense)
126.84%633.15K
131.42%743.05K
-232.03%-665.1K
195.45%398.09K
293.87%157.12K
-293.75%-2.36M
-542.15%-2.36M
516.29%503.75K
-296.65%-417.06K
-1,499.93%-81.04K
Gain on sale of security
126.84%633.15K
130.72%726.55K
-228.75%-648.61K
195.45%398.09K
293.87%157.12K
-293.75%-2.36M
-542.15%-2.36M
516.29%503.75K
-296.65%-417.06K
-1,499.93%-81.04K
Other non- operating income (expenses)
----
----
---16.5K
----
----
----
----
----
----
----
Income before tax
43.32%-4.88M
80.59%-787.62K
-252.57%-2.05M
57.84%-871.46K
38.49%-1.17M
-25.32%-8.6M
-164.32%-4.06M
60.77%-581.82K
11.12%-2.07M
-15.72%-1.9M
Income tax
2,075.72%377.97K
755.46%97.12K
742.29%42.59K
296.63%36.76K
5,856.25%201.5K
-41.82%17.37K
-61.98%11.35K
-6.63K
9.27K
3.38K
Net income
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-15.93%-1.9M
Net income continuous Operations
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-15.93%-1.9M
Minority interest income
Net income attributable to the parent company
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-15.93%-1.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-15.93%-1.9M
Basic earnings per share
96.03%-1.69
98.36%-0.11
75.72%-0.59
98.32%-0.28
96.37%-0.9
73.24%-42.58
80.47%-6.7011
92.77%-2.43
68.88%-16.62
36.83%-24.8
Diluted earnings per share
96.03%-1.69
98.36%-0.11
75.72%-0.59
98.32%-0.28
96.37%-0.9
73.24%-42.58
80.47%-6.7011
92.77%-2.43
68.88%-16.62
36.83%-24.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.86%5.74M-7.32%1.59M33.40%1.47M-21.29%1.3M-24.50%1.38M0.83%6.3M48.47%1.71M-18.36%1.1M-25.43%1.66M12.22%1.83M
Selling and administrative expenses -8.47%4.32M-18.44%1.06M34.14%1.13M-26.74%980.55K-7.14%1.16M52.21%4.72M751.01%1.3M-18.20%838.93K26.28%1.34M-4.27%1.25M
-General and administrative expense -8.47%4.32M-18.44%1.06M34.14%1.13M-26.74%980.55K-7.14%1.16M52.21%4.72M751.01%1.3M-18.20%838.93K26.28%1.34M-4.27%1.25M
Research and development costs -10.45%1.38M29.71%486.49K31.04%345.88K1.70%322.96K-61.29%227.48K-49.88%1.54M-70.79%375.07K-18.86%263.95K-72.64%317.57K76.75%587.63K
Depreciation amortization depletion 7.49%40.09K-----------------45.34%37.3K----------------
-Depreciation and amortization 7.49%40.09K-----------------45.34%37.3K----------------
Operating profit 8.86%-5.74M7.32%-1.59M-33.40%-1.47M21.29%-1.3M24.50%-1.38M-0.83%-6.3M-48.47%-1.71M18.36%-1.1M25.43%-1.66M-12.22%-1.83M
Net non-operating interest income expense 297.24%235.06K210.34%55.51K391.27%85.02K469.14%33.96K236.25%60.58K510.45%59.17K224.06%17.89K255.54%17.31K5.97K18.02K
Non-operating interest income 287.09%271.22K218.52%91.67K391.27%85.02K469.14%33.96K236.25%60.58K--70.07K--28.78K--17.31K--5.97K--18.02K
Non-operating interest expense 231.94%36.16K-----------------24.44%10.89K----------------
Other net income (expense) 126.84%633.15K131.42%743.05K-232.03%-665.1K195.45%398.09K293.87%157.12K-293.75%-2.36M-542.15%-2.36M516.29%503.75K-296.65%-417.06K-1,499.93%-81.04K
Gain on sale of security 126.84%633.15K130.72%726.55K-228.75%-648.61K195.45%398.09K293.87%157.12K-293.75%-2.36M-542.15%-2.36M516.29%503.75K-296.65%-417.06K-1,499.93%-81.04K
Other non- operating income (expenses) -----------16.5K----------------------------
Income before tax 43.32%-4.88M80.59%-787.62K-252.57%-2.05M57.84%-871.46K38.49%-1.17M-25.32%-8.6M-164.32%-4.06M60.77%-581.82K11.12%-2.07M-15.72%-1.9M
Income tax 2,075.72%377.97K755.46%97.12K742.29%42.59K296.63%36.76K5,856.25%201.5K-41.82%17.37K-61.98%11.35K-6.63K9.27K3.38K
Net income 39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-15.93%-1.9M
Net income continuous Operations 39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-15.93%-1.9M
Minority interest income
Net income attributable to the parent company 39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-15.93%-1.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-15.93%-1.9M
Basic earnings per share 96.03%-1.6998.36%-0.1175.72%-0.5998.32%-0.2896.37%-0.973.24%-42.5880.47%-6.701192.77%-2.4368.88%-16.6236.83%-24.8
Diluted earnings per share 96.03%-1.6998.36%-0.1175.72%-0.5998.32%-0.2896.37%-0.973.24%-42.5880.47%-6.701192.77%-2.4368.88%-16.6236.83%-24.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%
Apple
AAPL
+1.27%

Unlock the Full List